Cargando…

Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer

Aromatase inhibition is one of the cornerstones of modern endocrine therapy of oestrogen receptor-positive (ER+) metastatic breast cancer (MBC). The nonsteroidal aromatase inhibitors anastrozole and letrozole, as well as the steroidal aromatase inactivator exemestane, are the preferred drugs and est...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daldorff, Stine, Mathiesen, Randi Margit Ruud, Yri, Olav Erich, Ødegård, Hilde Presterud, Geisler, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220158/ https://www.ncbi.nlm.nih.gov/pubmed/27923036 http://dx.doi.org/10.1038/bjc.2016.405

Ejemplares similares

Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
por: Bahrami, Nazli, et al.
Publicado: (2021)

Cotargeting among microRNAs in the brain
por: Cherone, Jennifer M., et al.
Publicado: (2019)

The Epidermal Growth Factor Receptor (EGFR / HER-1) Gatekeeper Mutation T790M Is Present in European Patients with Early Breast Cancer
por: Bemanian, Vahid, et al.
Publicado: (2015)

PICH and Cotargeted Plk1 Coordinately Maintain Prometaphase Chromosome Arm Architecture
por: Kurasawa, Yasuhiro, et al.
Publicado: (2010)

Production of wax esters in plant seed oils by oleosomal cotargeting of biosynthetic enzymes
por: Heilmann, Mareike, et al.
Publicado: (2012)

A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1
por: Li, Yanan, et al.
Publicado: (2020)

Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis
por: Kitai, Hiroki, et al.
Publicado: (2022)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer
por: Colomer, R, et al.
Publicado: (2005)

Genetic variants of CYP19 (aromatase) and breast cancer risk
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000)

MicroRNA-5110 regulates pigmentation by cotargeting melanophilin and WNT family member 1
por: Yang, Shanshan, et al.
Publicado: (2018)

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020)

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2023)

Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer
por: Shin, Sol-Bi, et al.
Publicado: (2019)

Association Study of Aromatase Gene (CYP19A1) in Essential Hypertension
por: Shimodaira, Masanori, et al.
Publicado: (2008)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
por: Magnani, Luca, et al.
Publicado: (2017)

Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
por: Grazia, G, et al.
Publicado: (2014)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
por: Siegelmann-Danieli, N, et al.
Publicado: (1999)

Cyp19a1 (Aromatase) Expression in the Xenopus Brain at Different Developmental Stages
por: Coumailleau, P, et al.
Publicado: (2014)

Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene
por: Unal, Edip, et al.
Publicado: (2018)

Pyridine based dual binding site aromatase (CYP19A1) inhibitors
por: Eissa, Ahmed G., et al.
Publicado: (2023)

Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia
por: Wang, Tingting, et al.
Publicado: (2019)

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA
por: Casey, Mika, et al.
Publicado: (2022)

Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
por: Nardi, Francesca, et al.
Publicado: (2023)

A case of Aromatase deficiency due to a novel CYP19A1 mutation
por: Gagliardi, Lucia, et al.
Publicado: (2014)

Evaluation of coding-independent functions of the transcribed bovine aromatase pseudogene CYP19P1
por: Chwalisz, Marina, et al.
Publicado: (2014)

Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer
por: Zins, Karin, et al.
Publicado: (2014)

A Novel Homozygous CYP19A1 Gene Mutation Causing Aromatase Deficiency
por: Hathi, Deep, et al.
Publicado: (2022)

Ursolic acid silences CYP19A1/aromatase to suppress gastric cancer growth
por: Ma, Wen‐Lung, et al.
Publicado: (2022)

A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
por: Liu, Lei, et al.
Publicado: (2013)

Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?
por: Geisler, J
Publicado: (2011)

The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women
por: Lin, Jennifer H., et al.
Publicado: (2012)

Chronic Antipsychotic Treatment Modulates Aromatase (CYP19A1) Expression in the Male Rat Brain
por: Bogus, Katarzyna, et al.
Publicado: (2019)

Inhibitory effect of chrysin on estrogen biosynthesis by suppression of enzyme aromatase (CYP19): A systematic review
por: Balam, Farinaz Hosseini, et al.
Publicado: (2020)

Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3
por: Lai, F, et al.
Publicado: (2013)

Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models
por: Tran, Khanh B., et al.
Publicado: (2022)

Pseudoprogression After Palbociclib with Aromatase Inhibitors Treatment in Metastatic Breast Cancer
por: Huang, Weiwei, et al.
Publicado: (2020)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b66gat7l9ntptja992oeohtl0o